British Bio-tech sets up US subsidiary
Thursday 02 December 1993
James Noble, finance director, said the development was a sign of the progress made in British Bio-tech's testing programme. 'There's no possibility of a drug getting recognised in the States without doing US clinical trials,' he said.
The new US company will operate from Annapolis in Maryland, a short drive from the FDA's Washington offices. It will also be close to other important medical centres, including the National Institute of Health and the National Cancer Institute.
The US operation will be headed by Peter McCann, who joins British Bio-tech after 20 years in the pharmaceutical industry with Marion Merrell Dow in the US and Europe.
Recent animal tests on virus- like particles have encouraged British Bio-tech to believe its Aids treatment, p24-VLP, can induce the response needed to combat viral infections.
Testing of the company's ovarian cancer product, Batimastat, has shown it to be well tolerated. Tests also suggest it could be used against a much wider range of cancers.
British Bio-tech's latest results show a second-quarter loss increased from pounds 1.8m to pounds 4.6m, which the company said was in line with its expectations. This means the loss in the six months to 31 October is up from pounds 4.7m to pounds 8.8m.
Analysts expect the company to lose about pounds 20m this year, as its drugs enter more costly testing in the later stages. British Bio-tech still had cash of pounds 39.3m at the end of the half.
The group incurred a pounds 142,000 loss on the July sale of its manufacturing business to Techne Corporation. This has left it with negligible turnover.
- 1 Cyclist who knocked down three-year-old girl says his life has been 'destroyed'
- 2 Chelsea victory parade: Chelsea mocked on Twitter as 'tens of fans' pack the streets of London
- 3 US warned by Chinese media to stop meddling or 'war will be inevitable'
- 4 Woman, 21, dies after taking contraceptive pill that 'caused fatal blood clot'
- 5 Isis burns woman alive for refusing to engage in 'extreme' sex act, UN says
Cyclist who knocked down three-year-old girl says his life has been 'destroyed'
US warned by Chinese media to stop meddling or 'war will be inevitable'
How China's richest man Li Hejun lost $15bn in an hour - and made a fortune
Isis burns woman alive for refusing to engage in 'extreme' sex act, UN says
Snoop Dogg on why he doesn't regret displaying misogyny towards women
As a white man, I'm surprised more women aren't tweeting the hashtag #KillAllWhiteMen
Scotland may have to leave the EU even if it votes to stay in, David Cameron confirms
The day that Britain resigned as a global power
SNP fury as HS2 finds 'no business case' for taking fast train service to Scotland
EU referendum: David Cameron's rules are a 'democratic disgrace', says French-born Scottish politician set to be denied a vote
A nation of inequality: How the UK is failing to feed its most vulnerable people
iJobs Money & Business
£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...
£45,000 - £55,000: Neil Pavier: Are you looking for your next opportunity for ...
£45,000 - £55,000: Sheridan Maine: Are you a newly qualified ACA/ACCA/ACMA qua...
£50,000 - £60,000: Laura Norton: Are you looking for an opportunity within a w...